Article info

Download PDFPDF
Validation of the Predictive Value of Modeled Human Chorionic Gonadotrophin Residual Production in Low-Risk Gestational Trophoblastic Neoplasia Patients Treated in NRG Oncology/Gynecologic Oncology Group–174 Phase III Trial

Authors

  1. Address correspondence and reprint requests to Benoit You, MD, PhD, Service d’Oncologie Médicale, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, F-69310. 165, chemin du grand Revoyet 69495 Pierre-Bénite, France. E-mail: benoit.you@chu-lyon.fr.

Citation

You B, Deng W, Hénin E, et al
Validation of the Predictive Value of Modeled Human Chorionic Gonadotrophin Residual Production in Low-Risk Gestational Trophoblastic Neoplasia Patients Treated in NRG Oncology/Gynecologic Oncology Group–174 Phase III Trial

Publication history

  • Received May 1, 2015
  • First published January 1, 2016.
Online issue publication 
January 01, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.